相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma
Nan Jiang et al.
EBIOMEDICINE (2020)
Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
MaIka Jangal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma
Qicai Han et al.
CANCER MEDICINE (2019)
Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies
Martina Barchitta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency
Naosuke Yokomichi et al.
LIVER CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma
Jiakai Mao et al.
JOURNAL OF CANCER (2019)
Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer
Kosar Babaei et al.
BIOMEDICINE-TAIWAN (2019)
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia
Antonella Di Costanzo et al.
ONCOGENE (2018)
Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocelluiar carcinoma patients
Gang Ning et al.
AGING-US (2018)
Particulate matter-induced epigenetic changes and lung cancer
Jinghong Li et al.
CLINICAL RESPIRATORY JOURNAL (2017)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer
Wang Yang Chen et al.
ONCOLOGY LETTERS (2017)
Current and future biomarkers in the treatment of colorectal cancer
Pieter-Jan Cuyle et al.
ACTA CLINICA BELGICA (2017)
A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro
Craig L. Parfett et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
Hao Zheng et al.
Oncotarget (2017)
Prognostic values of distinct CBX family members in breast cancer
Yuan-Ke Liang et al.
ONCOTARGET (2017)
Epigenetic balance of gene expression by Polycomb and COMPASS families
Andrea Piunti et al.
SCIENCE (2016)
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
Pier-Luc Clermont et al.
CLINICAL EPIGENETICS (2016)
Structure-Activity Relationships of Cbx7 Inhibitors, Including Selectivity Studies against Other Cbx Proteins
Chakravarthi Simhadri et al.
ACS OMEGA (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Yoshinaga Okugawa et al.
GASTROENTEROLOGY (2015)
Colorectal Cancer Biomarkers: Where Are We Now?
Maria Gonzalez-Pons et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins
Rong-gang Ma et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells
Vincent van den Boom et al.
BLOOD (2013)
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation
Zdenko Herceg et al.
CARCINOGENESIS (2013)
Polycomb complexes in stem cells and embryonic development
Luigi Aloia et al.
DEVELOPMENT (2013)
Marginal public health gain of screening for colorectal cancer: modelling study, based on WHO and national databases in the Nordic countries
Johann A. Sigurdsson et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2013)
Heterochromatin instability in cancer: From the Barr body to satellites and the nuclear periphery
Dawn M. Carone et al.
SEMINARS IN CANCER BIOLOGY (2013)
Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level
Young Rhee et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Nonoverlapping Functions of the Polycomb Group Cbx Family of Proteins in Embryonic Stem Cells
Lluis Morey et al.
CELL STEM CELL (2012)
Proliferation and tissue remodeling in cancer: the hallmarks revisited
E. K. Markert et al.
CELL DEATH & DISEASE (2012)
Chromatin higher-order structures and gene regulation
Guohong Li et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Epigenetics and colorectal cancer
Victoria Valinluck Lao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Charting histone modifications and the functional organization of mammalian genomes
Vicky W. Zhou et al.
NATURE REVIEWS GENETICS (2011)
Polycomb group protein-mediated repression of transcription
Lluis Morey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Polycomb group protein gene silencing, noncoding RNA, stem cells, and cancer
Randall S. Gieni et al.
BIOCHEMISTRY AND CELL BIOLOGY (2009)
The Human Protein Atlas - a tool for pathology
F. Ponten et al.
JOURNAL OF PATHOLOGY (2008)
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle
Henrik Daub et al.
MOLECULAR CELL (2008)
Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
Sun Lee et al.
PATHOLOGY INTERNATIONAL (2008)
Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences
Claudius Vincenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pc2 and SUMOylation
D. Wotton et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Optimal pathologic staging: Defining stage II disease
Carolyn C. Compton
CLINICAL CANCER RESEARCH (2007)
Proteomics analysis of the centromere complex from HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is a component of the CEN-complex, while BMI-1 is transiently co-localized with the centromeric region in interphase
C Obuse et al.
GENES TO CELLS (2004)
MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein
ZB Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
